Movatterモバイル変換


[0]ホーム

URL:


AU2003246486A1 - Pegylated erythropoietic compounds - Google Patents

Pegylated erythropoietic compounds

Info

Publication number
AU2003246486A1
AU2003246486A1AU2003246486AAU2003246486AAU2003246486A1AU 2003246486 A1AU2003246486 A1AU 2003246486A1AU 2003246486 AAU2003246486 AAU 2003246486AAU 2003246486 AAU2003246486 AAU 2003246486AAU 2003246486 A1AU2003246486 A1AU 2003246486A1
Authority
AU
Australia
Prior art keywords
pegylated
erythropoietic
compounds
erythropoietic compounds
pegylated erythropoietic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003246486A
Inventor
John Douglas Cossar
Lawrence T. Malek
Donald I. H. Stewart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cangene Corp
Original Assignee
Cangene Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cangene CorpfiledCriticalCangene Corp
Publication of AU2003246486A1publicationCriticalpatent/AU2003246486A1/en
Abandonedlegal-statusCriticalCurrent

Links

Classifications

Landscapes

AU2003246486A2002-07-192003-07-17Pegylated erythropoietic compoundsAbandonedAU2003246486A1 (en)

Applications Claiming Priority (3)

Application NumberPriority DateFiling DateTitle
US39675002P2002-07-192002-07-19
US60/396,7502002-07-19
PCT/CA2003/001020WO2004009627A1 (en)2002-07-192003-07-17Pegylated erythropoietic compounds

Publications (1)

Publication NumberPublication Date
AU2003246486A1true AU2003246486A1 (en)2004-02-09

Family

ID=30770946

Family Applications (1)

Application NumberTitlePriority DateFiling Date
AU2003246486AAbandonedAU2003246486A1 (en)2002-07-192003-07-17Pegylated erythropoietic compounds

Country Status (2)

CountryLink
AU (1)AU2003246486A1 (en)
WO (1)WO2004009627A1 (en)

Families Citing this family (95)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
WO2005084711A1 (en)*2004-03-022005-09-15Chengdu Institute Of Biological ProductsA pegylated recombinant erythropoietin that has in vivo activity
US20090311247A1 (en)*2005-01-252009-12-17Apollo Life Sciences LimitedMolecules and chimeric molecules thereof
WO2007010552A2 (en)*2005-03-172007-01-25Serum Institute Of India LimitedN- terminal peg conjugate of erythropoietin
EP2054074B8 (en)2006-08-042014-11-12Prolong Pharmaceuticals, LLCModified erythropoietin
AR067536A1 (en)2007-07-172009-10-14Hoffmann La Roche METHOD FOR OBTAINING A MONO-PEGILATED ERYTHROPOYETIN IN A SUBSTANTIALLY HOMOGENOUS FORM
CL2008002053A1 (en)2007-07-172009-05-22Hoffmann La Roche Method for the purification of a monopeglated erythropoietin (epompeg) which consists of providing a solution containing mono, poly and non-peglated erythropoietin and passing it through two steps of cation exchange chromatography and a method to produce epo mpeg that includes a purification method.
AU2008304111B2 (en)2007-09-272014-04-24Amgen Inc.Pharmaceutical formulations
EP2219602A1 (en)2007-11-152010-08-25Amgen, IncAqueous formulation of erythropoiesis stimulating protein stablised by antioxidants for parenteral administration
EP2247618B1 (en)2008-01-252014-06-11Amgen, IncFerroportin antibodies and methods of use
EP2620448A1 (en)2008-05-012013-07-31Amgen Inc.Anti-hepcidin antibodies and methods of use
EP3693014A1 (en)2008-11-132020-08-12The General Hospital CorporationMethods and compositions for regulating iron homeostasis by modulation bmp-6
GB0922354D0 (en)*2009-12-212010-02-03Polytherics LtdNovel polymer conjugates
US9662271B2 (en)2009-10-232017-05-30Amgen Inc.Vial adapter and system
SG194370A1 (en)2010-06-072013-11-29Amgen IncDrug delivery device
CA2831100C (en)2011-03-312020-02-18Mark Dominis HoltVial adapter and system
PL2699293T3 (en)2011-04-202019-08-30Amgen Inc.Autoinjector apparatus
DK3045187T3 (en)2011-10-142019-06-11Amgen Inc INJECTOR AND COLLECTION PROCEDURE
CA3206182A1 (en)2012-11-212014-05-30Amgen Inc.Drug delivery device including insertion member and reservoir
ES2973257T3 (en)2013-03-152024-06-19Amgen Inc Drug cassette, autoinjector and autoinjector system
ES2695166T3 (en)2013-03-152019-01-02Intrinsic Lifesciences Llc Antihepcidin antibodies and uses thereof
CA2904661C (en)2013-03-152022-03-15Amgen Inc.Drug cassette, autoinjector, and autoinjector system
BR112015022042B1 (en)2013-03-152023-01-10Amgen Inc INJECTOR FOR INJECTING A THERAPEUTIC PRODUCT
SG11201507878SA (en)2013-03-222015-10-29Amgen IncInjector and method of assembly
JP7051293B2 (en)2013-10-242022-04-11アムジエン・インコーポレーテツド Drug delivery system with temperature sensing control
BR112016008946B1 (en)2013-10-242022-12-27Amgen Inc INJECTORS AND METHOD FOR ASSEMBLING THE INJECTORS
WO2015119906A1 (en)2014-02-052015-08-13Amgen Inc.Drug delivery system with electromagnetic field generator
MX388536B (en)2014-05-072025-03-20Amgen Inc AUTO-INJECTOR WITH SHOCK-REDUCING ELEMENTS.
CN106470717B (en)2014-06-032020-09-11安姆根有限公司 Drug delivery system and method of use
EP3197915A4 (en)2014-09-222018-12-19Intrinsic Lifesciences LLCHumanized anti-hepcidin antibodies and uses thereof
MX2021014323A (en)2014-10-142023-02-02Amgen IncDrug injection device with visual and audio indicators.
JP6716566B2 (en)2014-12-192020-07-01アムジエン・インコーポレーテツド Drug delivery device with proximity sensor
US11357916B2 (en)2014-12-192022-06-14Amgen Inc.Drug delivery device with live button or user interface field
CA2976935C (en)2015-02-172020-03-10Amgen Inc.Drug delivery device with vacuum assisted securement and/or feedback
EP3981450A1 (en)2015-02-272022-04-13Amgen, IncDrug delivery device having a needle guard mechanism with a tunable threshold of resistance to needle guard movement
WO2017039786A1 (en)2015-09-022017-03-09Amgen Inc.Syringe assembly adapter for a syringe
JP7082568B2 (en)2015-12-092022-06-08アムジエン・インコーポレーテツド Automatic syringe with signal transduction cap
US11154661B2 (en)2016-01-062021-10-26Amgen Inc.Auto-injector with signaling electronics
EP4035711B1 (en)2016-03-152025-06-04Amgen Inc.Reducing probability of glass breakage in drug delivery devices
WO2017189089A1 (en)2016-04-292017-11-02Amgen Inc.Drug delivery device with messaging label
US11389588B2 (en)2016-05-022022-07-19Amgen Inc.Syringe adapter and guide for filling an on-body injector
MX2018013616A (en)2016-05-132019-02-21Amgen IncVial sleeve assembly.
EP3458988B1 (en)2016-05-162023-10-18Amgen Inc.Data encryption in medical devices with limited computational capability
WO2017209899A1 (en)2016-06-032017-12-07Amgen Inc.Impact testing apparatuses and methods for drug delivery devices
WO2018004842A1 (en)2016-07-012018-01-04Amgen Inc.Drug delivery device having minimized risk of component fracture upon impact events
US20190328965A1 (en)2016-08-172019-10-31Amgen Inc.Drug delivery device with placement detection
EP3532127A1 (en)2016-10-252019-09-04Amgen Inc.On-body injector
JP2020503976A (en)2017-01-172020-02-06アムジエン・インコーポレーテツド Injection device and associated methods of use and assembly
AU2018221351B2 (en)2017-02-172023-02-23Amgen Inc.Insertion mechanism for drug delivery device
AU2018220538B2 (en)2017-02-172023-12-14Amgen Inc.Drug delivery device with sterile fluid flowpath and related method of assembly
JP2020508803A (en)2017-03-062020-03-26アムジエン・インコーポレーテツド Drug delivery device with anti-actuation feature
SG11201908058UA (en)2017-03-072019-09-27Amgen IncNeedle insertion by overpressure
IL268386B2 (en)2017-03-092023-11-01Amgen Inc Insertion mechanism for a drug delivery device
EP3570871B1 (en)2017-03-202020-11-18H. Hoffnabb-La Roche AgMethod for in vitro glycoengineering of an erythropoiesis stimulating protein
CN114588404B (en)2017-03-282024-07-09美国安进公司Plunger rod and syringe assembly system and method
JP7200134B2 (en)2017-06-082023-01-06アムジエン・インコーポレーテツド Torque driven drug delivery device
EP3634539A1 (en)2017-06-082020-04-15Amgen Inc.Syringe assembly for a drug delivery device and method of assembly
MX2019015472A (en)2017-06-222020-02-19Amgen IncDevice activation impact/shock reduction.
CA3063921A1 (en)2017-06-232018-12-27Amgen Inc.Electronic drug delivery device comprising a cap activated by a switch assembly
ES2972207T3 (en)2017-07-142024-06-11Amgen Inc Needle insertion-retraction system with double torsion spring system
MA49626A (en)2017-07-212020-05-27Amgen Inc GAS PERMEABLE SEALING ELEMENT FOR DRUG CONTAINER AND ASSEMBLY PROCEDURES
MA49677A (en)2017-07-252021-04-21Amgen Inc DRUG DELIVERY DEVICE WITH GEAR MODULE AND ASSOCIATED ASSEMBLY PROCESS
MA49676A (en)2017-07-252020-06-03Amgen Inc DRUG ADMINISTRATION DEVICE EQUIPPED WITH A CONTAINER ACCESS SYSTEM AND ASSOCIATED ASSEMBLY PROCEDURE
MA49838A (en)2017-08-092020-06-17Amgen Inc DRUG DELIVERY SYSTEM WITH CHAMBER HYDRAULIC-PNEUMATIC PRESSURE
MA49897A (en)2017-08-182020-06-24Amgen Inc ON-BODY INJECTOR WITH STERILE ADHESIVE PATCH
US11103636B2 (en)2017-08-222021-08-31Amgen Inc.Needle insertion mechanism for drug delivery device
EP3691717B1 (en)2017-10-042023-02-08Amgen Inc.Flow adapter for drug delivery device
US11813426B2 (en)2017-10-062023-11-14Amgen Inc.Drug delivery device including seal member for needle of syringe
MA50348A (en)2017-10-092020-08-19Amgen Inc DRUG ADMINISTRATION DEVICE INCLUDING A TRAINING ASSEMBLY AND ASSOCIATED ASSEMBLY PROCEDURE
WO2019090086A1 (en)2017-11-032019-05-09Amgen Inc.Systems and approaches for sterilizing a drug delivery device
CA3079197A1 (en)2017-11-062019-05-09Amgen Inc.Drug delivery device with placement and flow sensing
US12053618B2 (en)2017-11-062024-08-06Amgen Inc.Fill-finish assemblies and related methods
MX2020004736A (en)2017-11-102020-08-13Amgen IncPlungers for drug delivery devices.
EP3710090A1 (en)2017-11-162020-09-23Amgen Inc.Door latch mechanism for drug delivery device
CN111263651B (en)2017-11-162022-06-17安进公司Auto-injector with pause and end point detection
US10835685B2 (en)2018-05-302020-11-17Amgen Inc.Thermal spring release mechanism for a drug delivery device
US11083840B2 (en)2018-06-012021-08-10Amgen Inc.Modular fluid path assemblies for drug delivery devices
MA53379A (en)2018-07-242021-06-02Amgen Inc ADMINISTRATION DEVICES FOR THE ADMINISTRATION OF MEDICINES
WO2020023336A1 (en)2018-07-242020-01-30Amgen Inc.Hybrid drug delivery devices with grip portion
WO2020023220A1 (en)2018-07-242020-01-30Amgen Inc.Hybrid drug delivery devices with tacky skin attachment portion and related method of preparation
MA53375A (en)2018-07-242021-06-02Amgen Inc ADMINISTRATION DEVICES FOR THE ADMINISTRATION OF MEDICINES
MA53320A (en)2018-07-312021-11-03Amgen Inc FLUID PATH ASSEMBLY FOR DRUG DELIVERY DEVICE
CA3106452A1 (en)2018-09-242020-04-02Amgen Inc.Interventional dosing systems and methods
AU2019350660B2 (en)2018-09-282024-09-26Amgen Inc.Muscle wire escapement activation assembly for a drug delivery device
MX2021003492A (en)2018-10-022021-06-18Amgen Inc INJECTION SYSTEMS FOR THE ADMINISTRATION OF DRUGS WITH TRANSMISSION OF INTERNAL FORCE.
CA3112214A1 (en)2018-10-052020-04-09Amgen Inc.Drug delivery device having dose indicator
SG11202101824VA (en)2018-10-152021-03-30Amgen IncPlatform assembly process for drug delivery device
KR20250127186A (en)2018-10-152025-08-26암젠 인크Drug delivery device having damping mechanism
MA54048A (en)2018-11-012022-02-09Amgen Inc DRUG DELIVERY DEVICES WITH PARTIAL RETRACTION OF DRUG DELIVERY BODY
IL281908B2 (en)2018-11-012025-06-01Amgen Inc Drug delivery devices with partial drug delivery unit withdrawal
TWI831847B (en)2018-11-012024-02-11美商安進公司Drug delivery devices with partial needle retraction and methods for operating the same
CA3137360A1 (en)2019-04-242020-10-29Amgen Inc.Syringe sterilization verification assemblies and methods
US20220273887A1 (en)2019-08-232022-09-01Amgen Inc.Drug delivery device with configurable needle shield engagement components and related methods
WO2022033480A1 (en)*2020-08-112022-02-17隆延生物科技(上海)有限公司Liquid preparation and application thereof
IL307418A (en)2021-05-212023-12-01Amgen IncMethod of optimizing a filling recipe for a drug container
WO2024094457A1 (en)2022-11-022024-05-10F. Hoffmann-La Roche AgMethod for producing glycoprotein compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US4904584A (en)*1987-12-231990-02-27Genetics Institute, Inc.Site-specific homogeneous modification of polypeptides
AU6709794A (en)*1993-04-211994-11-08Brigham And Women's HospitalErythropoietin muteins with enhanced activity
IL110669A (en)*1993-08-172008-11-26Kirin Amgen IncErythropoietin analogs
DK1123313T3 (en)*1998-10-232007-06-18Amgen Inc Methods and compositions for the prevention and treatment of anemia
CA2352538A1 (en)*1998-11-302000-06-08Eli Lilly And CompanyErythropoietic compounds

Also Published As

Publication numberPublication date
WO2004009627A1 (en)2004-01-29

Similar Documents

PublicationPublication DateTitle
AU2003246486A1 (en)Pegylated erythropoietic compounds
AU2003266949A1 (en)Compounds
AU2003274037A1 (en)1-phenylpyrrolidine-2-one-3-carboxamides
AU2003202910A1 (en)Pivotable strap-buckle assembly
AU2003221098A1 (en)Oligofluorenylene compounds
AU2003279366A1 (en)Novel compounds
AU2003229066A1 (en)Interface architecture
AU2002354472A1 (en)Combine
AU2003216859A1 (en)Amidoacetonitrile compounds
AU2003221379A1 (en)High-temperature-sterilizable instillator
AU2003279630A1 (en)Puzzle
AU2003298156A1 (en)Biphenylcarboxamides
AU2003271584A1 (en)Opacificiers
AU2002355026A1 (en)Combine
AU2003251259A1 (en)Novel compounds
AU2003292667A1 (en)Benzocycloheptapyridine compounds
AU2003255322A1 (en)Compounds
AU2003275480A1 (en)Compounds
AUPR996302A0 (en)Jaggacomb
AU2003226541A1 (en)Novel compounds
AU2003239772A1 (en)Low-energy-diet
AU2002100287A4 (en)Tagz designs
AU2002100498A4 (en)Linline
AU2002100280A4 (en)Proshoe
AU2002953150A0 (en)Fluoress concept

Legal Events

DateCodeTitleDescription
MK6Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase

[8]ページ先頭

©2009-2025 Movatter.jp